Anti-IFN-γ, Human, Goat-Poly

データシート※最新のデータシートでない場合があります

• 商品コード：AF-285-NA
• メーカー：RSD
• 包装：100μg
• 価格： ¥106,000
• 在庫：無(未発注)

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Subauste CS et al. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer. J. Immunol. 1999 J
  Subauste CS et al
  1999/01/01
  
• 備考：
  Species: Mouse, Application: Neutralization, Whole Cells
• 参照：
  

• No.： 2
• 文献情報：
  Saetta M et al. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2002 May;165(10):1404-9
  Saetta M et al
  2002/01/01
  
• 備考：
  Species: Human, Application: IHC Paraffin-embedded, Sample type: Whole Tissue
• 参照：
  

• No.： 3
• 文献情報：
  Hu X et al. Sensitization of IFN-gamma Jak-STAT signaling during macrophage activation. Nat. Immunol. 2002 Sep;3(9):859-66
  Hu X et al
  2002/01/01
  
• 備考：
  Application: Neutralization, Sample Type: Whole Cells
• 参照：
  

• No.： 4
• 文献情報：
  Hessian PA et al. Cytokine profile of the rheumatoid nodule suggests that it is a Th1 granuloma. Arthritis Rheum. 2003 Feb;48(2):334-8
  Hessian PA et al
  2003/01/01
  
• 備考：
  Application: IHC, Sample Type: Whole Tissue
• 参照：
  

• No.： 5
• 文献情報：
  Ethuin F et al. Human neutrophils produce interferon gamma upon stimulation by interleukin-12. Lab. Invest. 2004 Oct;84(10):1363-71
  Ethuin F et al
  2004/01/01
  
• 備考：
  Application: Neutralization, Sample Type: Whole Cells
• 参照：
  

• No.： 6
• 文献情報：
  Kabashima H et al. Presence of CXCR3-positive cells and IFN-gamma-producing cells in human periapical granulomas. J Endod 2004 Sep;30(9):634-7
  Kabashima H et al
  2004/01/01
  
• 備考：
  Application: IHC Fresh/Frozen, Sample Type: Whole Tissue
• 参照：
  

• No.： 7
• 文献情報：
  Alexander C et al. Fel d 1-derived T cell peptide therapy induces recruitment of CD4+ CD25+; CD4+ interferon-gamma+ T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects. Clin. Exp. Allergy 2005 Jan;35(1):52
  Alexander C et al
  2005/01/01
  
• 備考：
  Application: IHC Fresh/Frozen, Sample Type: Whole Tissue
• 参照：
  

• No.： 8
• 文献情報：
  Han R et al. Induction by IL-1 beta of tissue inhibitor of metalloproteinase-1 in human orbital fibroblasts: modulation of gene promoter activity by IL-4 and IFN-gamma. J. Immunol. 2005 Mar;174(5):3072-9
  Han R et al
  2005/01/01
  
• 備考：
  Application: Neutralization, Sample Type: Whole Cells
• 参照：
  

• No.： 9
• 文献情報：
  Liu TY et al. Distinct subsets of human invariant NKT cells differentially regulate T helper responses via dendritic cells. Eur. J. Immunol. 2008 Apr;38(4):1012-23
  Liu TY et al
  2008/01/01
  
• 備考：
  Species: Human, Application: Neutralization, Whole Cells
• 参照：
  

• No.： 10
• 文献情報：
  Hu Y et al. IFN-gamma and STAT1 arrest monocyte migration and modulate RAC/CDC42 pathways. J. Immunol. 2008 Jun;180(12):8057-65
  Hu Y et al
  2008/01/01
  
• 備考：
  Species: Human, Application: Functional Assay, Whole Cells
• 参照：
  

• No.： 11
• 文献情報：
  Chi W et al. Upregulated IL-23 and IL-17 in Behテθ津つァet patients with active uveitis. Invest. Ophthalmol. Vis. Sci. 2008 Jul;49(7):3058-64
  Chi W et al
  2008/01/01
  
• 備考：
  Species: Human, Application: Neutralization, Whole Cells
• 参照：
  

• No.： 12
• 文献情報：
  Harigai M et al. Excessive production of IFN-gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell-activating factor/TNF ligand superfamily-13B. J. Immunol. 2008 Aug;181(3):2211-9
  Harigai M et al
  2008/01/01
  
• 備考：
  Species: Human, Application: Functional Assay, Whole Cells
• 参照：
  

• No.： 13
• 文献情報：
  Kobayashi A et al. Evolving immunosuppressive microenvironment during human cervical carcinogenesis. Mucosal Immunol 2008 Sep;1(5):412-20
  Kobayashi A et al
  2008/01/01
  
• 備考：
  Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
• 参照：
  

• No.： 14
• 文献情報：
  Heo YJ et al. IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+ T cell population of rheumatoid arthritis patients. Immunol. Lett. 2010 Jan;127(2):150-6
  Heo YJ et al
  2010/01/01
  
• 備考：
  Application: Neutralization, Sample Type: Whole Cells
• 参照：
  

• No.： 15
• 文献情報：
  Guo PF et al. Thymic stromal lymphopoietin from trophoblasts induces dendritic cell-mediated regulatory TH2 bias in the decidua during early gestation in humans. Blood 2010 Sep;116(12):2061-9
  Guo PF et al
  2010/01/01
  
• 備考：
  Application: IHC - Not specified, Sample Type: Whole Tissue
• 参照：
  

• No.： 16
• 文献情報：
  Mishto M et al. Immunoproteasome expression is induced in mesial temporal lobe epilepsy. Biochem. Biophys. Res. Commun. 2011 Apr;408(1):65-70
  Mishto M et al
  2011/01/01
  
• 備考：
  Application: Western Blot, Sample Type: Homogenized Tissue
• 参照：
  

• No.： 17
• 文献情報：
  Knoblach T et al. Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activated STAT1 but not interferon-?. PLoS Pathog. 2011 Apr;7(4):e1002016
  Knoblach T et al
  2011/01/01
  
• 備考：
  Application: Neutralization, Sample Type: Whole Cells
• 参照：
  

• No.： 18
• 文献情報：
  Wang R et al. Natural killer cell-produced IFN-γ and TNF-α induce target cell cytolysis through up-regulation of ICAM-1. J. Leukoc. Biol. 2012 Feb;91(2):299-309
  Wang R et al
  2012/01/01
  
• 備考：
  Application: Neutralization, Sample Type: Whole Cells
• 参照：
  

• No.： 19
• 文献情報：
  Zheng J et al. The Therapeutic Effect of Pamidronate on Lethal Avian Influenza A H7N9 Virus Infected Humanized Mice. PLoS ONE 2015;10(8):e0135999
  Zheng J et al
  2015/01/01
  
• 備考：
  Application: Neutralization, Sample Type: Whole Cells
• 参照：
  

• No.： 20
• 文献情報：
  Zou F et al. Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56. Nat Commun 2019 09;10(1):4109
  Zou F et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 21
• 文献情報：
  Shan L et al. Killer cell proteases can target viral immediate-early proteins to control human cytomegalovirus infection in a noncytotoxic manner. PLoS Pathog 2020 04;16(4):e1008426
  Shan L et al
  2020/01/01
  
• 備考：
  Species: Human, Applications: Neutralization
• 参照：